Human mesenchymal progenitors derived from H9 hES cells. Vimentin immunoreactivity (red) and nuclei (blue) are overlaid on a transmitted light image.
The SKI Stem Cell Research Facility expands, characterizes and distributes human pluripotent stem cells (hPSCs). We are a part of the Starr Foundation-funded Tri-Institutional Stem Cell Initiative that provides shared stem cell expertise and resources between Memorial Sloan Kettering, Weill-Cornell, and Rockefeller University. In addition to characterizing new Tri- Institutional hES lines, we provide :
- Training in hPSC culture
- Transgenic hESCs and services
- Directed differentiation from mouse or human ES cells
- Shared equipment
- Reprogramming fibroblasts to induced pluripotent stem cells (iPSCs)
Additionally, we continually refine technologies for genetic manipulation, gene expression and analysis, and reprogramming to offer state-of-the-art services to the Tri-Institutional community.